Genetics and molecular pathology of gastric malignancy: Development of targeted therapies in the era of personalized medicine

Michael Van Ness, Jeffrey Gregg, Jun Wang, Mingyi Chen

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Gastric malignancy constitutes a major cause of cancer deaths worldwide. Despite recent advances in surgical techniques combined with neoadjuvant chemotherapy and radiotherapy approaches, patients with advanced disease still have poor outcomes. An emerging understanding of the molecular pathways that characterize cell growth, cell cycle, apoptosis, angiogenesis, invasion and metastasis has provided novel targets in gastric cancer therapy. In this review, recent advances in the understanding of molecular tumorigenesis for common gastric malignancies are discussed. We also briefly review the current targeted therapies in the treatment of gastric malignancies. Practical insights are highlighted including HER2 testing and target therapy in gastric adenocarcinoma, morphologic features and molecular signatures of imatinib-resistance GISTs, and recent investigations aimed at tumor-specific therapy for neuroendocrine tumors.

Original languageEnglish (US)
Pages (from-to)243-250
Number of pages8
JournalJournal of Gastrointestinal Oncology
Volume3
Issue number3
DOIs
StatePublished - Jan 1 2012

Fingerprint

Precision Medicine
Molecular Pathology
Stomach
Neoplasms
Therapeutics
Neuroendocrine Tumors
Stomach Neoplasms
Cause of Death
Cell Cycle
Carcinogenesis
Adenocarcinoma
Radiotherapy
Apoptosis
Neoplasm Metastasis
Drug Therapy
Growth

Keywords

  • Gastric malignancy
  • Genetics and molecular pathology
  • Targeted therapy

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology

Cite this

Genetics and molecular pathology of gastric malignancy : Development of targeted therapies in the era of personalized medicine. / Van Ness, Michael; Gregg, Jeffrey; Wang, Jun; Chen, Mingyi.

In: Journal of Gastrointestinal Oncology, Vol. 3, No. 3, 01.01.2012, p. 243-250.

Research output: Contribution to journalReview article

@article{732ad1bbd54641ee959bea52ba03c398,
title = "Genetics and molecular pathology of gastric malignancy: Development of targeted therapies in the era of personalized medicine",
abstract = "Gastric malignancy constitutes a major cause of cancer deaths worldwide. Despite recent advances in surgical techniques combined with neoadjuvant chemotherapy and radiotherapy approaches, patients with advanced disease still have poor outcomes. An emerging understanding of the molecular pathways that characterize cell growth, cell cycle, apoptosis, angiogenesis, invasion and metastasis has provided novel targets in gastric cancer therapy. In this review, recent advances in the understanding of molecular tumorigenesis for common gastric malignancies are discussed. We also briefly review the current targeted therapies in the treatment of gastric malignancies. Practical insights are highlighted including HER2 testing and target therapy in gastric adenocarcinoma, morphologic features and molecular signatures of imatinib-resistance GISTs, and recent investigations aimed at tumor-specific therapy for neuroendocrine tumors.",
keywords = "Gastric malignancy, Genetics and molecular pathology, Targeted therapy",
author = "{Van Ness}, Michael and Jeffrey Gregg and Jun Wang and Mingyi Chen",
year = "2012",
month = "1",
day = "1",
doi = "10.3978/j.issn.2078-6891.2012.017",
language = "English (US)",
volume = "3",
pages = "243--250",
journal = "Journal of Gastrointestinal Oncology",
issn = "2078-6891",
publisher = "Pioneer Bioscience Publishing Company (PBPC)",
number = "3",

}

TY - JOUR

T1 - Genetics and molecular pathology of gastric malignancy

T2 - Development of targeted therapies in the era of personalized medicine

AU - Van Ness, Michael

AU - Gregg, Jeffrey

AU - Wang, Jun

AU - Chen, Mingyi

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Gastric malignancy constitutes a major cause of cancer deaths worldwide. Despite recent advances in surgical techniques combined with neoadjuvant chemotherapy and radiotherapy approaches, patients with advanced disease still have poor outcomes. An emerging understanding of the molecular pathways that characterize cell growth, cell cycle, apoptosis, angiogenesis, invasion and metastasis has provided novel targets in gastric cancer therapy. In this review, recent advances in the understanding of molecular tumorigenesis for common gastric malignancies are discussed. We also briefly review the current targeted therapies in the treatment of gastric malignancies. Practical insights are highlighted including HER2 testing and target therapy in gastric adenocarcinoma, morphologic features and molecular signatures of imatinib-resistance GISTs, and recent investigations aimed at tumor-specific therapy for neuroendocrine tumors.

AB - Gastric malignancy constitutes a major cause of cancer deaths worldwide. Despite recent advances in surgical techniques combined with neoadjuvant chemotherapy and radiotherapy approaches, patients with advanced disease still have poor outcomes. An emerging understanding of the molecular pathways that characterize cell growth, cell cycle, apoptosis, angiogenesis, invasion and metastasis has provided novel targets in gastric cancer therapy. In this review, recent advances in the understanding of molecular tumorigenesis for common gastric malignancies are discussed. We also briefly review the current targeted therapies in the treatment of gastric malignancies. Practical insights are highlighted including HER2 testing and target therapy in gastric adenocarcinoma, morphologic features and molecular signatures of imatinib-resistance GISTs, and recent investigations aimed at tumor-specific therapy for neuroendocrine tumors.

KW - Gastric malignancy

KW - Genetics and molecular pathology

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=84995740348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995740348&partnerID=8YFLogxK

U2 - 10.3978/j.issn.2078-6891.2012.017

DO - 10.3978/j.issn.2078-6891.2012.017

M3 - Review article

C2 - 22943015

AN - SCOPUS:84995740348

VL - 3

SP - 243

EP - 250

JO - Journal of Gastrointestinal Oncology

JF - Journal of Gastrointestinal Oncology

SN - 2078-6891

IS - 3

ER -